Chemistry Service Platform - CRO in Medicinal Chemistry

Axon Ligands (TM) - alphabetic: [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z]





CPI 613



CAS 95809-78-2

C22H28O2S2  MW 388.59

Purity: 100%

Soluble in basic aq. solution

Soluble in DMSO






Ordering Information:


Cat. No. Axon 2125    


1 x 10 mg / 105  $137

Promotion: 2 x 10 mg  @  160  $208

1 x 50 mg / 350  $455

Bulk on request


Send enquiry to:


Contact us for payment and tech support.


Certificate of Analysis (CoA): current batch 
Safety Data Sheet (MSDS):  view



Biological Activity:


A small molecular inhibitor of a mitochondrial enzyme pyruvate dehydrogenase (PDH) complex; CPI-613 selectively attacks the regulatory aspects of tumor cell mitochondrial metabolism, activating both apoptotic (programmed cell death) and non-apoptotic (necrosis-like) cell death pathways.




Z Zachar et al. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J. Mol. Med. (Berl). 2011, 89(11), 1137-1148. [online]


KC Lee et al. Formation and anti-tumor activity of uncommon in vitro and in vivo metabolites of CPI-613, a novel anti-tumor compound that selectively alters tumor energy metabolism. Drug Metab. Lett. 2011, 5(3), 163-182. [online]



Chemical Name: 6,8-Bis(benzylthio)octanoic acid


CPI 613 | PDH inhibitor | Axon 2125 | CPI613 from supplier Axon Medchem

Axon Ligands TM  - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis. 2013


Axon Ligands in The Field:


CPI 613 | PDH inhibitor



See Featured Cell Signaling and Oncology Ligands from Axon Ligands Collection